Yi Cai, MD
Pain Medicine · la Jolla, CANPI 1497142293
Payments from drug & device makers
Across 133 payments — averaging $168.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$17K
- Abbott$3K
- Nevro Corp.$652
- Medtronic$283
- Si-bone, Inc.$259
- Relievant Medsystems, Inc.$207
- plus $695 from 14 others
What the payments were for
- Grants$15,00067%
- Travel & lodging$9294%
- Food & beverage$6,34628%
- Education$740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 22 | $16,884 |
| Abbott | 57 | $3,370 |
| Nevro Corp. | 16 | $652 |
| Medtronic | 13 | $283 |
| Si-bone, Inc. | 2 | $259 |
| Relievant Medsystems, Inc. | 2 | $207 |
| GRT US Holding, Inc. | 3 | $154 |
| MML US, Inc. | 1 | $137 |
| Painteq LLC | 3 | $85 |
| SPR Therapeutics, Inc | 2 | $78 |
| Stimwave Technologies Incorporated | 2 | $43 |
| Lilly USA, LLC | 2 | $33 |
| Viiv Healthcare Company | 1 | $25 |
| Apollo Endosurgery US Inc | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $21 |
| Nalu Medical, Inc. | 1 | $19 |
| Vertos Medical, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$15,813
- Proclaim IPG$717
- Proclaim Family of SCS IPGs$711
- Intracept$237
- WAVEWRITER ALPHA$231
- Senza Spinal Cord Stimulation System$139
- ReActiv8$137
- iFuse Implant$126
- SUPERION$113
- GENERAL PAIN MANAGEMENT$107
- INTELLIS$101
How this compares
$22,349 in reported general payments places this provider in the 85th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 105 | $2,682 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $930 |
| Pregabalin | 31 | $855 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $765 |
| Tizanidine Hcl | 37 | $561 |
| Celecoxib | 12 | $334 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in la Jolla
- Farshad Ahadianla Jolla$349K
- Imanuel Lermanla Jolla$66K
- Eric GrigsbyNapa$3.2M
- Jason PopeSanta Rosa$2.8M
- Javid GhandehariSanta Monica$2.7M
- Alexander HerselThousand Oaks$2.1M
- Krishnan ChakravarthyTemecula$1.9M
- Kasra AmirdelfanWalnut Creek$1.7M
- Ramana NaiduLarkspur$1.6M
- Foead GeulaStudio City$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.